Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
Clinical trial NCT00233558 · TERMINATED
Trial details
- NCT number
- NCT00233558
- Sponsor
- Abbott
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.